RT @JACCJournals: In this Editorial Comment, Drs. @onco_cardiology (Lopez-Mattei) w/ Drs. @PalaskasN and Iliescu, discuss how #CardioOnc is…
Predicting CardioToxicity of Anthracycline
RT @JACCJournals: In this Editorial Comment, Drs. @onco_cardiology (Lopez-Mattei) w/ Drs. @PalaskasN and Iliescu, discuss how #CardioOnc is…
RT @JACCJournals: In this Editorial Comment, Drs. @onco_cardiology (Lopez-Mattei) w/ Drs. @PalaskasN and Iliescu, discuss how #CardioOnc is…
RT @JACCJournals: In this Editorial Comment, Drs. @onco_cardiology (Lopez-Mattei) w/ Drs. @PalaskasN and Iliescu, discuss how #CardioOnc is…
RT @JACCJournals: In this Editorial Comment, Drs. @onco_cardiology (Lopez-Mattei) w/ Drs. @PalaskasN and Iliescu, discuss how #CardioOnc is…
RT @JACCJournals: In this Editorial Comment, Drs. @onco_cardiology (Lopez-Mattei) w/ Drs. @PalaskasN and Iliescu, discuss how #CardioOnc is…
RT @JACCJournals: In this Editorial Comment, Drs. @onco_cardiology (Lopez-Mattei) w/ Drs. @PalaskasN and Iliescu, discuss how #CardioOnc is…
RT @JACCJournals: In this Editorial Comment, Drs. @onco_cardiology (Lopez-Mattei) w/ Drs. @PalaskasN and Iliescu, discuss how #CardioOnc is…
RT @JACCJournals: In this Editorial Comment, Drs. @onco_cardiology (Lopez-Mattei) w/ Drs. @PalaskasN and Iliescu, discuss how #CardioOnc is…
RT @JACCJournals: In this Editorial Comment, Drs. @onco_cardiology (Lopez-Mattei) w/ Drs. @PalaskasN and Iliescu, discuss how #CardioOnc is…
RT @JACCJournals: In this Editorial Comment, Drs. @onco_cardiology (Lopez-Mattei) w/ Drs. @PalaskasN and Iliescu, discuss how #CardioOnc is…
RT @JACCJournals: In this Editorial Comment, Drs. @onco_cardiology (Lopez-Mattei) w/ Drs. @PalaskasN and Iliescu, discuss how #CardioOnc is…
RT @JACCJournals: In this Editorial Comment, Drs. @onco_cardiology (Lopez-Mattei) w/ Drs. @PalaskasN and Iliescu, discuss how #CardioOnc is…
RT @JACCJournals: In this Editorial Comment, Drs. @onco_cardiology (Lopez-Mattei) w/ Drs. @PalaskasN and Iliescu, discuss how #CardioOnc is…
RT @JACCJournals: In this Editorial Comment, Drs. @onco_cardiology (Lopez-Mattei) w/ Drs. @PalaskasN and Iliescu, discuss how #CardioOnc is…
RT @JACCJournals: In this Editorial Comment, Drs. @onco_cardiology (Lopez-Mattei) w/ Drs. @PalaskasN and Iliescu, discuss how #CardioOnc is…
RT @JACCJournals: In this Editorial Comment, Drs. @onco_cardiology (Lopez-Mattei) w/ Drs. @PalaskasN and Iliescu, discuss how #CardioOnc is…
RT @JACCJournals: In this Editorial Comment, Drs. @onco_cardiology (Lopez-Mattei) w/ Drs. @PalaskasN and Iliescu, discuss how #CardioOnc is…
RT @JACCJournals: In this Editorial Comment, Drs. @onco_cardiology (Lopez-Mattei) w/ Drs. @PalaskasN and Iliescu, discuss how #CardioOnc is…
RT @JACCJournals: In this Editorial Comment, Drs. @onco_cardiology (Lopez-Mattei) w/ Drs. @PalaskasN and Iliescu, discuss how #CardioOnc is…
In this Editorial Comment, Drs. @onco_cardiology (Lopez-Mattei) w/ Drs. @PalaskasN and Iliescu, discuss how #CardioOnc is advancing w/ Kang et al. research on clinical endpoints such as systemic #heartfailure to monitor cardiotoxicity. https://t.co/FSJrd8q
@hull_md @Sugeng_Lissa @CardioOnc_MR_CT Agree Sarah. I am a bit skeptical about the benefit of protecting from “subclinical cardiotoxicity” low risk patients. This doesn’t have an established benefit well defined by hard endpoints. https://t.co/WqXdFOPRq6
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @venkmurthy: Well written commentary on the issues with defining and diagnosing anthracycline cardiotoxicity by @onco_cardiology https:/…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @venkmurthy: Well written commentary on the issues with defining and diagnosing anthracycline cardiotoxicity by @onco_cardiology https:/…
RT @venkmurthy: Well written commentary on the issues with defining and diagnosing anthracycline cardiotoxicity by @onco_cardiology https:/…
Well written commentary on the issues with defining and diagnosing anthracycline cardiotoxicity by @onco_cardiology
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @mariellesc1 nice paper 👉🏼https://t.co/clRzz0yZuj of baseline predictors of symptomatic HF in patients w/ leukemia treated with Anthracy